Atlas Trials

A Trial of the Effect of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subjects

Clinical trial NCT04592536 · COMPLETED

Trial details

NCT number
NCT04592536
Sponsor
Cerevel Therapeutics, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Panic Disorder
Start date
2020-10-06
Primary completion
2021-11-14
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.